Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Burger

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Neuro-Oncology|June 9, 2025
Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology GroupClaire Mazewski, Sarah E S Leary, Guolian Kang, et al.
Acta Neuropathologica|August 13, 2015
A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutationCheng-Ying Ho, Bret C Mobley, Heather Gordish-Dressman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Reply to S.A. UpadhyayaAlyssa T Reddy, Mark D Krailo, Allen B Buxton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology ConsortiumFaith G Davis, Beatrice S Malmer, Ken Aldape, et al.
Cancer|August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsJ Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Pediatric Blood & Cancer|July 1, 2010
Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology GroupIan F Pollack, Ronald L Hamilton, Robert W Sobol, et al.
International Journal of Cancer|September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastomaSarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.
International Journal of Cancer|August 3, 2019
Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer typesDimitrios Mathios, Taeyoung Hwang, Yuanxuan Xia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 TrialEugene I Hwang, Marcel Kool, Peter C Burger, et al.
Journal of Neurosurgery. Spine|February 4, 2010
Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshopElizabeth B Claus, May Abdel-Wahab, Peter C Burger, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Neuro-Oncology|June 9, 2025
Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology GroupClaire Mazewski, Sarah E S Leary, Guolian Kang, et al.
Acta Neuropathologica|August 13, 2015
A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutationCheng-Ying Ho, Bret C Mobley, Heather Gordish-Dressman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Reply to S.A. UpadhyayaAlyssa T Reddy, Mark D Krailo, Allen B Buxton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology ConsortiumFaith G Davis, Beatrice S Malmer, Ken Aldape, et al.
Cancer|August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsJ Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Pediatric Blood & Cancer|July 1, 2010
Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology GroupIan F Pollack, Ronald L Hamilton, Robert W Sobol, et al.
International Journal of Cancer|September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastomaSarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.
International Journal of Cancer|August 3, 2019
Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer typesDimitrios Mathios, Taeyoung Hwang, Yuanxuan Xia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 TrialEugene I Hwang, Marcel Kool, Peter C Burger, et al.
Journal of Neurosurgery. Spine|February 4, 2010
Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshopElizabeth B Claus, May Abdel-Wahab, Peter C Burger, et al.
Pageof 16